One blood test can diagnose diabetes
According to a study, published in theAnnals of Internal Medicine, measuring HbA1c and fasting glucose blood levels from a single sample is sufficient to accurately diagnose diabetes.MedPage Today
The precision-targeted therapies show early, encouraging signs of reduced toxicities for medullary, thyroid cancers.Medscape Medical News
ConclusionsThe disease burden of MHE is quite substantial in patients with cirrhosis with no apparent cognitive defect. Smoking, whether past or current, has significant association with the presence of MHE. Though MHE has been shown to adversely affect quality of life, prophylaxis for MHE is not routinely practiced in the Indian setting.The study has been registered under clinical trials registry of India (CTRI/2014/01/004306).
CONCLUSIONS: The current smartphone applications for DM are characterized by a limited number of participants, a small number of parameters, and a lack of standardization. PMID: 30317460 [PubMed - as supplied by publisher]
AbstractPurposeTo clarify the relevance between smoking and diabetic retinopathy in patients with type 1 and type 2 diabetes mellitus.MethodsPublished evidence were searched in MEDLINE and EMBASE from the databases began until Feb. 2017. Studies evaluating the association between smoking and diabetic retinopathy or evaluating the risk factors of diabetic retinopathy including smoking were included.ResultsTotally 73 studies were identified, among which 19 studies included type 1 diabetes patients and 56 studies included type 2 diabetes patients. In type 1 diabetes, compare with non-smokers, the risk of diabetic retinopathy ...
ConclusionsIn the real-life scenario ~54% of patients with acromegaly resistant to first-generation SSA, may normalize IGF-1 with pasireotide; however, 63% experienced glucose control deterioration.
ConclusionsIt seems that adequate melatonin treatment exerts anti-obesity protective effects, also in a diet-induced obesity zebrafish model, that might be the result of the restoration of many factors: the final endpoint reached is weight loss and stabilization of weight gain.
(MedPage Today) -- Rates tended to be higher for those on insulin versus oral agents
Shares in Valeritas (NSDQ:VLRX) fell today after the medical technology company announced its preliminary financial results for the third quarter of 2018. The Bridgewater, N.J.-based company said it expects to post quarterly revenue of approximately $6.9 million, just ahead of the $6.85 million predicted by analysts. Compared to the same period in 2017, Valeritas’ sales are up 36%. Get the full story at our sister site, Drug Delivery Business News. The post Valeritas shares fall despite Street-beating Q3 prelims appeared first on MassDevice.
This article is part of a series of opinion pieces to mark World Food Day October 16 José Graziano da Silva is Director-General of the Food and Agriculture Organization of the United NationsThe post Zero Hunger: our actions today are our future tomorrow appeared first on Inter Press Service.
Condition: Type 2 Diabetes Mellitus Interventions: Other: Usual Care; Behavioral: Intensive Behavioral Intervention; Other: Monthly Screening for Risk Sponsors: University of Michigan; Twine Clinical Consulting Not yet recruiting